Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
- April -
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
- 2008 -
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
April 2008 - 46 products
IP
CI
CM
Andreavit
30
PR
PR
k.A.
Coated tablets: 20 Active Agents
Andreabal AG
D
FB
G
IP
CI
CM
Andreavit
90
PR
PR
k.A.
Coated tablets: 20 Active Agents
Andreabal AG
D
FB
G
L
IP
CI
Janumet 50/500
-
T
56 Tablet(s)
23.69
41.30
20 %
Coated tablets: 2 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
L
IP
CI
Janumet 50/500
-
T
196 Tablet(s)
82.94
103.55
20 %
Coated tablets: 2 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
L
IP
CI
Janumet 50/850
-
T
56 Tablet(s)
23.69
41.30
20 %
Coated tablets: 2 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
L
IP
CI
Janumet 50/850
-
T
196 Tablet(s)
82.94
103.55
20 %
Coated tablets: 2 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
L
IP
CI
Janumet 50/1000
-
T
56 Tablet(s)
23.69
41.30
20 %
Coated tablets: 2 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
L
IP
CI
Janumet 50/1000
-
T
196 Tablet(s)
82.94
103.55
20 %
Coated tablets: 2 Active Agents
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
L
SIP
IP
CI
Galvus 50 mg
-
T
28 Tablet(s)
13.06
30.45
20 %
Tablets: Vildagliptinum 50 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
SIP
IP
CI
Galvus 50 mg
-
T
112 Tablet(s)
52.25
72.60
20 %
Tablets: Vildagliptinum 50 mg
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
L
IP
CI
Ondansetron-Teva 4 oro
10 Tablet(s)
22.60
40.95
10 %
Melting tablets: Ondansetronum 4 mg
Teva Pharma AG
B / SL / SG
FB
G
L
IP
CI
Ondansetron-Teva 8 oro
6 Tablet(s)
22.61
40.95
10 %
Melting tablets: Ondansetronum 8 mg
Teva Pharma AG
B / SL / SG
FB
G
IP
CI
CM
Fexofenadine Zentiva 120 mg
10 Tablet(s)
2.85
5.25
10 %
Coated tablets: Fexofenadini Hydrochloridum 120 mg
Helvepharm AG
D / SL / SG
FB
G
IP
CI
CM
Fexofenadine Zentiva 120 mg
30
7.70
14.20
10 %
Coated tablets: Fexofenadini Hydrochloridum 120 mg
Helvepharm AG
D / SL / SG
FB
G
IP
CI
CM
Fexofenadine Zentiva 180 mg
10
3.91
7.20
10 %
Coated tablets: Fexofenadini Hydrochloridum 180 mg
Helvepharm AG
D / SL / SG
FB
G
IP
CI
CM
Fexofenadine Zentiva 180 mg
30
10.59
19.55
10 %
Coated tablets: Fexofenadini Hydrochloridum 180 mg
Helvepharm AG
D / SL / SG
FB
G
IP
CI
Finasterid Zentiva 5 mg
30
12.31
29.90
10 %
Coated tablets: Finasteridum 5 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Finasterid Zentiva 5 mg
100
53.56
74.65
10 %
Coated tablets: Finasteridum 5 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Lansoprazol Sandoz 15
14 Capsule(s)
5.65
15.35
10 %
Capsules: Lansoprazolum 15 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Lansoprazol Sandoz 15
28 Capsule(s)
9.33
26.60
10 %
Capsules: Lansoprazolum 15 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Lansoprazol Sandoz 15
56 Capsule(s)
17.15
35.05
10 %
Capsules: Lansoprazolum 15 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Lansoprazol Sandoz 15
112 Capsule(s)
30.69
49.70
10 %
Capsules: Lansoprazolum 15 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Lansoprazol Sandoz 30
‐
I
14 Capsule(s)
8.83
26.00
10 %
Capsules: Lansoprazolum 30 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Lansoprazol Sandoz 30
28 Capsule(s)
15.47
33.20
10 %
Capsules: Lansoprazolum 30 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Lansoprazol Sandoz 30
56 Capsule(s)
25.83
44.55
10 %
Capsules: Lansoprazolum 30 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
V/S
Privigen
Flasche(n)
167.14
198.20
10 %
Infusion solution: Immunoglobulinum Humanum Normale
CSL Behring AG
B / SL
FB
G
L
IP
V/S
Privigen
Flasche(n)
334.27
379.95
10 %
Infusion solution: Immunoglobulinum Humanum Normale
CSL Behring AG
B / SL
FB
G
L
IP
V/S
Privigen
Flasche(n)
668.54
743.50
10 %
Infusion solution: Immunoglobulinum Humanum Normale
CSL Behring AG
B / SL
FB
G
L
IP
V/S
Privigen
Flasche(n)
1337.09
1470.60
10 %
Infusion solution: Immunoglobulinum Humanum Normale
CSL Behring AG
B / SL
FB
G
L
IP
V/S
Privigen
Flasche(n)
2674.18
2924.75
10 %
Infusion solution: Immunoglobulinum Humanum Normale
CSL Behring AG
B / SL
FB
G
IP
CI
Moviprep
2 Sachet(s)
11.51
28.95
10 %
Soluble Powder: 2 Active Agents
Soluble Powder: 4 Active Agents
Norgine AG
B / SL
FB
G
IP
CI
Femadiol-Mepha 20
21 Dragée(s)
PR
14.65
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 20
3 x 21 Dragée(s)
PR
39.95
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 20
6 x 21 Dragée(s)
PR
69.20
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 30
21 Dragée(s)
PR
14.65
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 30
3 x 21 Dragée(s)
PR
39.95
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Femadiol-Mepha 30
6 x 21 Dragée(s)
PR
69.20
k.A.
Dragées: 2 Active Agents
Mepha Pharma AG
B / LPPV
FB
G
IP
CI
Lansoprazol Sandoz 15
14 Capsule(s)
PR
PR
k.A.
Capsules: Lansoprazolum 15 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Lansoprazol Sandoz 15
28 Capsule(s)
PR
PR
k.A.
Capsules: Lansoprazolum 15 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Lansoprazol Sandoz 15
56 Capsule(s)
PR
PR
k.A.
Capsules: Lansoprazolum 15 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Lansoprazol Sandoz 15
112 Capsule(s)
PR
PR
k.A.
Capsules: Lansoprazolum 15 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Lansoprazol Sandoz 30
14 Capsule(s)
PR
PR
k.A.
Capsules: Lansoprazolum 30 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Lansoprazol Sandoz 30
28 Capsule(s)
PR
PR
k.A.
Capsules: Lansoprazolum 30 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
CI
Lansoprazol Sandoz 30
56 Capsule(s)
PR
PR
k.A.
Capsules: Lansoprazolum 30 mg
Sandoz
Pharmaceuticals AG
B
FB
G
IP
Kaliumchlorid 7.5 %
10 1 Vial(s) à 50 ml
PR
PR
k.A.
Konzentrat zur Herstellung einer Infusionslösung (Vial): 3 Active Agents
Laboratorium Dr. G.
Bichsel AG
B
FB
G
IP
Kaliumchlorid Bichsel 15 %
10 1 Vial(s) à 50 ml
PR
PR
k.A.
Konzentrat zur Herstellung einer Infusionslösung (Vial): 3 Active Agents
Laboratorium Dr. G.
Bichsel AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home